| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial intelligence (AI) | 26.80 | 615 |
| Intrinsic value (DCF) | 69.02 | 1741 |
| Graham-Dodd Method | n/a | |
| Graham Formula | n/a |
Ningxia Zhongke Biotechnology Co., Ltd. is a specialized chemical manufacturer based in Yinchuan, China, operating in the basic materials sector with a focus on steel industry applications. Founded in 1958, the company has evolved into a producer of coal-based activated carbon, lauric acid products, and bio-based chemical fibers. Despite its biotechnology-oriented name, the company primarily serves industrial markets with chemical raw materials essential for various manufacturing processes. Operating on the Shanghai Stock Exchange, Ningxia Zhongke leverages China's significant chemical production infrastructure while facing the challenges of a capital-intensive industry. The company's product portfolio positions it within the broader industrial chemicals landscape, serving filtration, purification, and specialty chemical applications. With its long-established presence in China's Ningxia region, the company maintains regional industrial relationships while competing in both domestic and international chemical markets.
Ningxia Zhongke Biotechnology presents a high-risk investment profile characterized by significant financial challenges. The company reported a substantial net loss of -539 million CNY on revenue of 345 million CNY for the period, indicating severe operational inefficiencies or market pressures. With negative operating cash flow of -85 million CNY and a relatively high debt load of 228 million CNY against limited cash reserves of 8.6 million CNY, the company faces liquidity constraints. The absence of dividends and persistent losses suggest ongoing restructuring or competitive challenges within China's chemical manufacturing sector. Investors should carefully assess the company's turnaround strategy and market positioning before considering exposure to this struggling industrial chemical producer.
Ningxia Zhongke Biotechnology operates in a highly competitive segment of China's chemical manufacturing industry, specializing in coal-based activated carbon and specialty chemicals. The company's competitive positioning appears challenged, as evidenced by its significant financial losses and negative cash flow. While its long-established presence since 1958 provides some historical market knowledge and regional relationships, this has not translated into sustainable competitive advantages. The company's biotechnology-oriented name suggests aspirations toward higher-value chemical production, but current operations remain focused on traditional industrial chemicals facing intense price competition. The steel industry classification indicates possible specialization in metallurgical chemicals, though this niche hasn't proven profitable recently. The company's small market capitalization of approximately 2.8 billion CNY positions it as a minor player in China's massive chemical sector, likely struggling against larger, more efficient producers with better economies of scale. The negative financial metrics across revenue, income, and cash flow suggest either operational inefficiencies, outdated technology, or unfavorable market conditions that have eroded any potential competitive advantages.